Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Biphenotypic, Acute 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, T-Cell 2Burkitt Lymphoma 2Rhabdoid Tumor 1Recurrence 1Pyloric Stenosis, Hypertrophic 1Prostatic Neoplasms 1Prostate Cancer Metastatic 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pinealoma 1Pancreatitis 1Pancreatic Intraductal Neoplasms 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Medulloblastoma 1Lymphoma, B-Cell 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myeloid, Acute 1Hodgkin Disease 1Hematopoietic and Lymphatic System Neoplasm 1Hematologic Neoplasms 1Fistula 1Duodenal Neoplasms 1Down Syndrome 1Blastic Plasmacytoid Dendritic Cell Neoplasm 1

Interventions

fludarabine 4Specimen Handling 2Cytarabine 2Cyclophosphamide 2trametinib 1thymoglobulin 1merphos 1imetelstat 1hydrocortisone hemisuccinate 1fludarabine phosphate 1Watchful Waiting 1Spinal Puncture 1Rituximab 1Methotrexate 1Melphalan 1Levetiracetam 1Leucovorin 1Injections 1Hydrocortisone 1Hematopoietic Stem Cell Transplantation 1GRN163L peptide 1Busulfan 1Biopsy 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Leukemia, Myelomonocytic, Juvenile × Hydrocortisone × Clear all
NCT06247787 2026-04-20

A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy

Children's Oncology Group

Phase 1 Recruiting
36 enrolled
Other hematologic neoplasm

Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡